<![CDATA[EU/3/16/1637 (Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues)

<![CDATA[EU/3/16/1637 (Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues) - Alnylam UK Limited]]> 1440 Copyright: (C) European Commission en-gb Tue, 29 Mar 2016 12:03:00 +0000 http://ec.europa.eu/health/documents/community-register/html/o1637.htm <![CDATA[EU/3/16/1637 (Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues) - Alnylam UK Limited]]> http://ec.europa.eu/health/documents/community-register/images/logo_en.gif http://ec.europa.eu/health/documents/community-register/html/o1637.htm 144 100 Orphan designation - Commission Decision (2016)1875 of Tue, 29 Mar 2016 New documents http://ec.europa.eu/health/documents/community-register/html/o1637.htm#proc134524 http://ec.europa.eu/health/documents/community-register/html/o1637.htm#proc134524 Tue, 29 Mar 2016 12:03:00 +0000